However, these pharmacological effects may exacerbate pre-existing nutritional deficiencies, particularly in protein and essential micronutrients, thereby increasing the risk of muscle loss and sarcopenia [24]
Similar content being viewed by others Introduction Cardiovascular disease (CVD) is a leading cause of death globally
Yes, GlowAgain is designed for individuals using GLP-1 medications like Mounjaro, Ozempic, Zepbound, Wegovy, or compounded semaglutide/tirzepatide to manage their treatment journey
They target macronutrients such as carbohydrates, fats, proteins, and lactose, supporting digestion primarily in the stomach and small intestine
Cagrilintides activity within this region influences downstream hypothalamic signaling pathways